Depression Severity Strongly Linked to Non-Fatal Cardiovascular Disease
November 13, 2019
A new study being presented next week at AHA's 2019 Scientific Sessions found a strong link between depression and non-fatal heart disease.
Sydney Jennings
Young Marijuana Users May be at Greater Risk for Stroke, Arrhythmia
November 11, 2019
Two studies to be presented at the upcoming AHA annual meeting found that young cannabis users are at greater risk for stroke and arrhythmia.
Obesity Overview: 7 Questions on the Latest Research
November 5, 2019
From nut consumption to abnormal bowel habits, test your knowledge of the latest research in obesity with this quick quiz.
Does Obesity Cause Acne? New Study, Surprising Results
October 25, 2019
In a new study of >600 000 Israeli adolescents, researchers found an inverse relationship between body mass index and acne.
New Artificial Pancreas Bests Current Technology for Glycemic Control
October 25, 2019
Type 1 diabetes patients who used the new system increased by 2.6 hours/day the amount of time spent in target blood glucose level range.
Vaping-Related Lung Injury: New CDC Recommendations for Primary Care Physicians
October 24, 2019
The multistate outbreak of vaping-related lung injury is ongoing, but the CDC's updated interim guidance can help physicians navigate the clinical evaluation and management of these patients.
Vaping-Related Lung Injury in the US: A Pop Quiz
October 22, 2019
How current are you on the outbreak of lung injuries associated with e-cigarette use, as of today? Take our pop quiz on the latest facts and figures to find out.
FDA Approves Breakthrough Medication for Cystic Fibrosis
October 22, 2019
Trikafta™ is the first triple combination therapy approved for the treatment of the most common cystic fibrosis mutation.
Best and Worst States for Vaccination in the US
October 14, 2019
From influenza to herpes zoster, which states ranked the best for vaccination? And which ones did not? Find out in this quick slideshow.
10 New Drugs for Primary Care: Q3 2019
October 10, 2019
The third quarter saw several novel drugs win FDA-approval for a variety of conditions often seen in primary care.
